The Pot Report. Get the Report
The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report

Author: <span>thepotreport</span>

Laws · November 16, 2026

Regulating Saint Lucia’s Cannabis Industry: Engaging Banks in the Transition

Saint Lucia cannabis banking was the focus of a late-October summit where regulators, bankers and officials discussed how a legal industry could use the formal financial system. Regulators proposed a seed-to-sale tracking system to ease bank worries. Government aims to launch the industry by 2027, with legislation heading to Parliament soon.

Why it matters: Cannabis businesses that cannot bank push money into cash, which makes oversight harder. For consumers and patients, access to licensed, taxed and traceable products depends partly on whether banks will serve the sector. Tracking tools like those proposed could shape how smoothly a legal market opens, though Saint Lucia's timeline remains a target, not a certainty.

Read moreSource: thevoiceslu.com

Medical · November 16, 2026

Is Alcohol or Marijuana Worse for Your Brain? – VICE

Psychiatrist Daniel Amen says alcohol kills more people than marijuana, yet in his clinics' brain imaging study of 62,454 SPECT scans, both substances sped up brain aging and marijuana did worse. Amen Clinics ranks cannabis use disorder second only to schizophrenia for accelerating brain aging and advises cutting back on both substances.

Why it matters: The marijuana vs alcohol brain debate rarely has a clean winner. Amen's clinic data suggests cannabis use disorder in particular is tied to faster brain aging, while alcohol carries its own heavy risks. For consumers and patients, the claims point to heavy or disordered use as the sticking point, though the findings come from one clinic's research.

Read moreSource: vice.com

Laws · November 16, 2026

Some hemp products are now illegal – many more could be next

A federal hemp ban on synthetic cannabinoids took effect Nov. 12, making some products illegal. The change comes from a spending bill President Trump signed in Nov. 2025 that redefined hemp. The broader limits, which could hit CBD oil and THC drinks, are delayed to Dec. 11. The FDA has yet to publish the required cannabinoid lists.

Why it matters: For consumers, the hemp ban on synthetic cannabinoids is already shrinking what can legally be sold, and more is coming. Without FDA lists, nobody can say for sure whether products like HHC or THC-P are covered, so shelves may shift unpredictably. Products with chemically converted cannabinoids could disappear from the federal definition of hemp on Dec. 11 unless Congress acts.

Read moreSource: GreenState

Profiles · New Jersey · November 16, 2026

Redman Says the People Making Weed Laws ‘Don’t Know Shit About Cannabis’

Rapper Redman is launching Muddy Waters, a hemp-derived THC coconut water, and says the move makes him a cannabis owner rather than a paid endorser. He built it with Matt and Krystal Hamlett Lovett of MoyoLove Juice Joint. Each can holds 10 mg of THC. He also backs federal descheduling through the United Empowerment Party.

Why it matters: A celebrity-backed THC drink is arriving just as hemp beverages face tighter rules. Under the federal redefinition taking effect December 11, finished hemp products above 0.4 mg total THC per container fall outside hemp unless Congress acts. A 10 mg can sits well over that line, so where and how buyers find such drinks could change.

Read moreSource: High Times

Profiles · November 16, 2026

Travis Barker Quit Smoking Weed After Precancer Diagnosis: ‘I Thought I Could Be Like Willie Nelson and Smoke to the Day I Die’

Travis Barker quit smoking weed after a doctor diagnosed him with precancer of the esophagus, the Blink-182 drummer said on Kid Cudi's podcast. Barker said the doctor called it a warning shot and ordered him to stop smoking. He tied his heavy blunt habit to the diagnosis and described running and exercise as tools that keep him sober.

Why it matters: Barker's account is a personal one, not a medical finding, and it does not show that cannabis caused his condition. It does show that a doctor told a heavy blunt smoker to stop smoking altogether. For consumers, it is a reminder that how much and how someone consumes can matter, and that edibles are one non-smoked route.

Read moreSource: High Times

Medical · Oklahoma · November 16, 2026

Federally Funded Study to Investigate Workplace Health Risks in Oklahoma Cannabis Industry

A University of Oklahoma researcher has won a federal grant to study workplace health risks in Oklahoma's medical cannabis industry. The CDC's National Institute for Occupational Safety and Health funded the work, which builds on a pilot study of worker exposures such as elevated carbon dioxide from plants and particulate matter from trimming and manufacturing. Hongwan (Melodi) Li leads the project.

Why it matters: Cannabis workers rarely get dedicated federal attention on job safety. Data on air quality and dust exposure in grow rooms and processing areas could eventually shape workplace standards, and that affects the people who produce the medicine patients buy. For consumers, it is a sign that regulators are starting to look at how products are made, not just sold.

Read moreSource: Ganjapreneur

The week in cannabis, in five minutes.Free, every week, from The Pot Report.
Get the Report
Laws · Pennsylvania · November 16, 2026

Likely Pennsylvania Senate Leader Says Cannabis Legalization Not High Priority

Pennsylvania cannabis legalization is not a top priority for incoming Senate President Pro Tempore Jay Costa, a Democrat. Costa told ABC27 lawmakers will likely discuss it, but he pointed to affordability, a higher minimum wage and regulating AI data centers as more pressing. Democrats will hold both chambers next year, and Gov. Josh Shapiro backs legalization.

Why it matters: A Democratic Senate majority had raised hopes that Pennsylvania adult-use legalization might finally clear the Capitol. Costa's comments signal that timing is uncertain. For now, only registered medical patients can legally buy cannabis in the state, and anyone hoping for recreational access should expect a wait, not a fast vote.

Read moreSource: Ganjapreneur

Laws · Wisconsin · November 16, 2026

Wisconsin Will ‘Definitely’ Legalize Marijuana Next Year, Top Democratic Senator Says As GOP Leader Says He’s Open To Discussing It

Wisconsin Democrats who will lead both legislative chambers say they intend to legalize marijuana within a year. Sen. Dianne Hesselbein and Rep. Greta Neubauer told WMTV they want it done in their first year in the majority. Republican Sen. Julian Bradley left the door open to talks but wants to read a bill first.

Why it matters: Wisconsin residents currently face criminal penalties for any amount of marijuana, so a stated legalization goal from the incoming majority is a real shift in tone. Nothing changes yet, and details such as clemency and hemp rules are unsettled. Republican willingness to talk suggests a bill could get a hearing, but passage is not assured.

Read moreSource: Marijuana Moment

Laws · Pennsylvania · November 16, 2026

Legalizing Marijuana In Pennsylvania Is Not A ‘High Priority’ For 2027, Top Senate Democrat Says

Marijuana legalization in Pennsylvania is not a high priority for 2027, according to incoming Senate President Pro Tempore Jay Costa, a Democrat. He told WHTM-TV the issue will be discussed in coming months but not right away, even though Democrats just won control of the Senate and Gov. Josh Shapiro backs reform.

Why it matters: Advocates had hoped a Democratic Senate would quickly open the door to adult-use sales. Costa's comments suggest that timeline is slipping. For now, Pennsylvanians who want legal cannabis should expect the medical-only system to stay in place, and the border-state purchases that lawmakers cite are likely to continue into 2027.

Read moreSource: Marijuana Moment

Medical · November 16, 2026

Boots to begin prescribing medical cannabis in UK – The Guardian

Boots has launched SureLeaf, an online medical cannabis prescribing service, making it the first UK high street pharmacy to do so. Patients aged 25 and over with eligible conditions such as chronic pain, anxiety or insomnia can apply. A clinical team reviews each case, and a research programme with the University of Nottingham will track outcomes.

Why it matters: A household-name pharmacy entering the medical cannabis market signals that prescribing is moving further into the mainstream. Patients get another route to a prescription, with a second consultant review and regular check-ins promised. Yet recent research found very little evidence for several conditions clinics treat, so access is widening faster than proof.

Read moreSource: theguardian.com